D-1165-2022 Class I Terminated
FDA drug recall D-1165-2022 was initiated by Green Pharmaceuticals, Inc. on June 9, 2022 and is designated Class I. Reason for recall: Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri. The recall status is terminated (terminated April 14, 2023). Affected quantity: 1074 spray bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- July 6, 2022
- Initiation Date
- June 9, 2022
- Termination Date
- April 14, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1074 spray bottles
Product Description
SnoreStop NasoSpray, 0.3 FL OZ (9 mL), Green Pharmaceuticals Inc. Camarillo, CA 93012, NDC 61152-199-99, UPC 7 69682 29101 3
Reason for Recall
Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.
Distribution Pattern
Nationwide within the United States
Code Information
Lot #: 2373/21222